Trevi Therapeutics, Inc. (TRVI)
13.14
-0.04
(-0.30%)
USD |
NASDAQ |
Oct 07, 16:00
13.14
0.00 (0.00%)
After-Hours: 20:00
Trevi Therapeutics EPS Diluted (Quarterly) : -0.1136 for June 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.1136 |
| March 31, 2026 | -0.0906 |
| December 31, 2025 | -0.0572 |
| September 30, 2025 | -0.0813 |
| June 30, 2025 | -0.0944 |
| March 31, 2025 | -0.0879 |
| December 31, 2024 | -0.1077 |
| September 30, 2024 | -0.1307 |
| June 30, 2024 | -0.1222 |
| March 31, 2024 | -0.1096 |
| December 31, 2023 | -0.0786 |
| September 30, 2023 | -0.0775 |
| June 30, 2023 | -0.0724 |
| March 31, 2023 | -0.0649 |
| December 31, 2022 | -0.0561 |
| September 30, 2022 | -0.12 |
| June 30, 2022 | -0.1352 |
| March 31, 2022 | -0.2379 |
| Date | Value |
|---|---|
| December 31, 2021 | -0.2989 |
| September 30, 2021 | -0.3358 |
| June 30, 2021 | -0.4867 |
| March 31, 2021 | -0.4311 |
| December 31, 2020 | -0.5185 |
| September 30, 2020 | -0.4068 |
| June 30, 2020 | -0.414 |
| March 31, 2020 | -0.4751 |
| December 31, 2019 | -0.3665 |
| September 30, 2019 | -0.413 |
| June 30, 2019 | -0.6338 |
| March 31, 2019 | -0.345 |
| December 31, 2018 | -0.4138 |
| September 30, 2018 | -0.3988 |
| June 30, 2018 | -0.3363 |
| March 31, 2018 | -0.288 |
| December 31, 2017 | -0.2159 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| ANI Pharmaceuticals, Inc. | 1.052 |
| Corcept Therapeutics, Inc. | 0.356 |
| Veru, Inc. | -0.3032 |
| Johnson & Johnson | 2.268 |
| Eli Lilly & Co. | 7.939 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -17.80M |
| Total Expenses (Quarterly) | 17.80M |
| Enterprise Value | 1.553B |
| Earnings Yield | -2.61% |
| Normalized Earnings Yield | -2.608 |